Insmed, Inc. (INSM)
124.03
-1.74
(-1.38%)
USD |
NASDAQ |
Aug 24, 16:00
124.03
0.00 (0.00%)
After-Hours: 20:00
Insmed Net Income (Quarterly) : -13.24M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -13.24M |
| March 31, 2026 | -163.56M |
| December 31, 2025 | -328.48M |
| September 30, 2025 | -370.02M |
| June 30, 2025 | -321.69M |
| March 31, 2025 | -256.58M |
| December 31, 2024 | -235.55M |
| September 30, 2024 | -220.52M |
| June 30, 2024 | -300.61M |
| March 31, 2024 | -157.09M |
| December 31, 2023 | -186.06M |
| September 30, 2023 | -158.93M |
| June 30, 2023 | -244.81M |
| March 31, 2023 | -159.76M |
| December 31, 2022 | -160.12M |
| September 30, 2022 | -131.14M |
| June 30, 2022 | -95.64M |
| March 31, 2022 | -94.62M |
| December 31, 2021 | -112.98M |
| September 30, 2021 | -112.71M |
| June 30, 2021 | -117.32M |
| March 31, 2021 | -91.64M |
| December 31, 2020 | -102.21M |
| September 30, 2020 | -63.66M |
| June 30, 2020 | -61.85M |
| Date | Value |
|---|---|
| March 31, 2020 | -66.36M |
| December 31, 2019 | -52.99M |
| September 30, 2019 | -60.68M |
| June 30, 2019 | -66.51M |
| March 31, 2019 | -74.15M |
| December 31, 2018 | -91.57M |
| September 30, 2018 | -87.74M |
| June 30, 2018 | -76.44M |
| March 31, 2018 | -68.52M |
| December 31, 2017 | -65.38M |
| September 30, 2017 | -45.18M |
| June 30, 2017 | -44.67M |
| March 31, 2017 | -37.41M |
| December 31, 2016 | -68.40M |
| September 30, 2016 | -37.76M |
| June 30, 2016 | -36.58M |
| March 31, 2016 | -33.53M |
| December 31, 2015 | -31.24M |
| September 30, 2015 | -30.96M |
| June 30, 2015 | -28.61M |
| March 31, 2015 | -27.37M |
| December 31, 2014 | -17.65M |
| September 30, 2014 | -23.99M |
| June 30, 2014 | -23.22M |
| March 31, 2014 | -14.30M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| United Therapeutics Corp. | 333.00M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Biogen, Inc. | 97.50M |
| Gilead Sciences, Inc. | -10.50B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 425.49M |
| Total Expenses (Quarterly) | 438.73M |
| EPS Diluted (Quarterly) | -0.0609 |
| Enterprise Value | 27.04B |
| Gross Profit Margin (Quarterly) | 83.71% |
| Profit Margin (Quarterly) | -3.11% |
| Earnings Yield | -3.31% |
| Normalized Earnings Yield | -3.228 |